RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196,595 | -27.0% | 228,121 | +1.6% | 0.00% | – |
| Q2 2023 | $269,485 | -44.0% | 224,571 | +307.8% | 0.00% | – |
| Q1 2023 | $481,251 | -2.9% | 55,063 | -11.1% | 0.00% | – |
| Q4 2022 | $495,408 | +334.6% | 61,926 | +164.0% | 0.00% | – |
| Q3 2022 | $114,000 | -12.3% | 23,458 | 0.0% | 0.00% | – |
| Q2 2022 | $130,000 | -86.6% | 23,458 | -87.8% | 0.00% | – |
| Q1 2022 | $972,000 | -44.1% | 191,801 | +42.0% | 0.00% | – |
| Q4 2021 | $1,740,000 | +3.3% | 135,078 | +20.0% | 0.00% | – |
| Q3 2021 | $1,684,000 | +21.6% | 112,541 | +26.3% | 0.00% | – |
| Q2 2021 | $1,385,000 | – | 89,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,637,308 | $25,444,000 | 3.14% |
| Cormorant Asset Management, LP | 2,626,660 | $39,734,000 | 1.35% |
| BVF INC/IL | 1,945,949 | $30,240,000 | 1.13% |
| Logos Global Management LP | 780,331 | $12,126,000 | 1.02% |
| ACUTA CAPITAL PARTNERS, LLC | 162,245 | $2,521,000 | 1.01% |
| LUMINUS MANAGEMENT LLC | 425,000 | $6,605,000 | 0.96% |
| Boxer Capital, LLC | 1,175,000 | $18,260,000 | 0.64% |
| Perceptive Advisors | 5,074,038 | $78,850,000 | 0.51% |
| Lumina Fund Management LLC | 6,000 | $93,000 | 0.04% |
| Monashee Investment Management LLC | 20,000 | $311,000 | 0.04% |